BD Kiestra
Advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
| Date | Investors | Amount | Round |
|---|---|---|---|
€420k | Grant | ||
N/A | Acquisition | ||
| Total Funding | $462k | ||
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (1 %) | 18 % | (7 %) | 3 % | 4 % | 8 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 23 % | 26 % | 24 % | 24 % | 26 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 5 % | 10 % | 9 % | 8 % | 8 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 6 % | 7 % | 7 % | 6 % | 6 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
BD (Becton, Dickinson and Company) is a leading global medical technology firm dedicated to advancing the world of health. The company operates in various segments including BD Medical, BD Life Sciences, and BD Interventional, each focusing on different aspects of healthcare. BD serves a wide range of clients including hospitals, laboratories, and healthcare providers across North America, EMEA (Europe, Middle East, and Africa), Greater Asia, and Latin America.
BD's business model revolves around the development, manufacturing, and sale of medical devices, laboratory equipment, and diagnostic products. The company generates revenue through the sale of these products and services, which are designed to improve medical discovery, diagnostics, and the delivery of care.
BD's innovative solutions help customers enhance patient outcomes, lower healthcare costs, increase operational efficiencies, improve safety, and expand access to healthcare services.
Keywords: medical technology, diagnostics, healthcare, medical devices, laboratory equipment, patient outcomes, cost efficiency, safety, global market, innovation.